Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Opinion and Evidence in Cancer

Opinion and Evidence in Cancer reality in the clinic. Of note, are the exciting results shown recently using targeted molecular therapies. To help you keep up-to-date with the latest advances worldwide on all aspects of drug therapy and management of cancer, this section of the journal brings you information selected from the drug therapy reporting service Inpharma Weekly . Each issue contains easy-to-read summaries of the most important research and development news, clinical studies, treatment guidelines, pharmacoeconomic and adverse reaction news, and expert opinion pieces published in the world’s top oncology publications. Chemoradiotherapy superior to radiotherapy 1. Chemotherapy in head and neck cancer Concurrent chemotherapy and radiotherapy is superior to ra- Although surgery remains the cornerstone of therapy in head diotherapy alone and should be considered the standard of care and neck cancer, chemotherapy is playing an increasingly impor- tant part in both improving survival and organ preservation, say in patients with locally advanced unresectable squamous cell car- Dr Forastiere and colleagues from the Johns Hopkins University cinoma of all sites in the head and neck, as well as in patients with School of Medicine, Baltimore, USA. stage III or IV cancers of the oropharynx in whom nonsurgical 1 Inpharma Weekly provides rapid alerts http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cancer Springer Journals

Opinion and Evidence in Cancer

American Journal of Cancer , Volume 1 (2) – Aug 9, 2012

Loading next page...
 
/lp/springer-journals/opinion-and-evidence-in-cancer-NJD7qJkrX0
Publisher
Springer Journals
Copyright
Copyright © 2002 by Adis International Limited
Subject
Pharmacy; Pharmacy
ISSN
1175-6357
DOI
10.2165/00024669-200201020-00009
Publisher site
See Article on Publisher Site

Abstract

reality in the clinic. Of note, are the exciting results shown recently using targeted molecular therapies. To help you keep up-to-date with the latest advances worldwide on all aspects of drug therapy and management of cancer, this section of the journal brings you information selected from the drug therapy reporting service Inpharma Weekly . Each issue contains easy-to-read summaries of the most important research and development news, clinical studies, treatment guidelines, pharmacoeconomic and adverse reaction news, and expert opinion pieces published in the world’s top oncology publications. Chemoradiotherapy superior to radiotherapy 1. Chemotherapy in head and neck cancer Concurrent chemotherapy and radiotherapy is superior to ra- Although surgery remains the cornerstone of therapy in head diotherapy alone and should be considered the standard of care and neck cancer, chemotherapy is playing an increasingly impor- tant part in both improving survival and organ preservation, say in patients with locally advanced unresectable squamous cell car- Dr Forastiere and colleagues from the Johns Hopkins University cinoma of all sites in the head and neck, as well as in patients with School of Medicine, Baltimore, USA. stage III or IV cancers of the oropharynx in whom nonsurgical 1 Inpharma Weekly provides rapid alerts

Journal

American Journal of CancerSpringer Journals

Published: Aug 9, 2012

There are no references for this article.